Abstract:Background: Seminoma accounts for the most part of cases of testicular germ cell tumor, which is the most common malignancy among males between ages 15 and 44 years. Understanding the molecular mechanism of tumorigenesis is important for better clinical diagnosis and treatment. Purpose: We performed bioinformatics analysis to better understand seminoma at the genetic level and to explore potential candidate genes or molecules for diagnosis, treatment, and prognosis. Methods: A gene expression profile (GSE8607), containing 40 seminoma samples and three healthy testes samples, was analyzed to identify differentially expressed genes (DEGs) associated with the occurrence of seminoma. Functional annotation was then performed using gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. Cytoscape with Search Tool for the Retrieval of Interacting Genes was used to construct a protein-protein interaction (PPI) network of the DEGs and select hub genes. Moreover, validation of expression level and Kaplan-Meier analysis for overall survival were conducted to those hub genes. Results: A total of 1,636 DEGs were identified between seminoma and healthy samples, including 701 up-regulated in seminoma that were enriched in the regulation of immune responses, defense responses, receptor activity, and signal transducer activity; 935 were down-regulated in seminoma and were associated with reproductive processes, kinase activity, and carbohydrate derivative binding. Five hub genes were selected from the PPI network according to the degree of connectivity: IL6, VEGFA, IL10, CCR5, and CXCR4. Among them, high expression levels of CCR5 and CXCR4 were associated with poor prognosis for seminoma patients. Four modules selected from the PPI network revealed that seminoma was connected with the Janus kinase-signal transducers and activators of transcription signaling pathway, chemokine signaling pathway, endocytosis, and cytokine-cytokine receptor interaction. Conclusion: These identified DEGs and hub genes facilitate our knowledge of the underlying molecular mechanism of seminoma and have the potential to be used as diagnostic biomarkers or therapeutic targets for seminoma.

Expression and Significance of CD147 in Seminoma Tissues

The expression and clinical significance of CD147 in testicular tumor

[Expression and Significance of CD147 Protein in Prostate Cancer].

[Expression of Human Testis Development Related Gene 1 in Testicular Cancer Detected by Tissue Microarray].

Specific expression of CD147 in prostate cancer tissues

CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer

Expression and Clinical Significance of CD147 in Renal Cell Carcinoma: a Meta-Analysis.

Over-expressed CD 147 may be a reminder of tumor progression in cervical lesions : an immunohistochemical investigation with 494 cases

Expression of CD147 is Associated with Prostate Cancer Progression

Expression and clinical significance of CD147 in genitourinary carcinomas.

Expression of CD147 Protein in Human Cervical Carcinoma

Clinical Significance of PSMA Gene Expression in Prostate Cancer Tissue

[Expression and Clinical Significance of HAb18G/CD147 in Malignant Tumors].

Identification of Key Genes and Pathways in Seminoma by Bioinformatics Analysis

Semen As a Rich Source of Diagnostic Biomarkers for Prostate Cancer: Latest Evidence and Implications

The expression of CD147 and PTEN in non small cell lung cancer and their correlation with clinical pathological factors

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Expression of CD44 is associated with aggressiveness in seminomas

Expression of CD147 in Human Glioma and Its Clinical Significance

[Expression and Significance of CD147 and E-cadherin in Human Gastric Carcinoma].

Significance of expression of prostate stem cell antigen in human prostate cancer